Hemoperfusion Production Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Hemoperfusion Production market size was valued at USD 590.6 million in 2022 and is forecast to a readjusted size of USD 1546.2 million by 2029 with a CAGR of 14.7% during review period.

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body.

Global Hemoperfusion Production key players include Baxter (Gambro), Jafron Biomedical, Biosun Medical, Asahi-Kasei, etc. Global top four manufacturers hold a share over 80%. China is the largest market, with a share over 65%, followed by Europe, and Japan, both have a share about 30 percent. In terms of product, Resin Adsorption is the largest segment, with a share over 65%. And in terms of application, the largest application is Hepatic Encephalopathy, followed by Certain Autoimmune Diseases, Overdose, Specific Intoxications, etc.

This report is a detailed and comprehensive analysis for global Hemoperfusion Production market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Hemoperfusion Production market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Hemoperfusion Production market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Hemoperfusion Production market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Hemoperfusion Production market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hemoperfusion Production
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Hemoperfusion Production market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Jafron Biomedical
   Baxter (Gambro)
   Biosun Medical
   Toray Medical
   Asahi-Kasei
   Kaneka
   Zibo Kangbei
   Aier
   Cytosorbents

   Resin Adsorption
   Activated Carbon Adsorption
   Others

   Overdose
   Specific Intoxications
   Certain Autoimmune Diseases
   Hepatic Encephalopathy
   Others

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the Hemoperfusion Production Market in 2025?

The Hemoperfusion Production Market in 2025 benefits from technological advancements, providing more efficient and reliable devices. These systems help address acute poisoning and renal failure, offering a growing market opportunity in critical care units worldwide. Increased awareness and demand for advanced treatment options also drive market growth.

What are the weaknesses of the Hemoperfusion Production Market in 2025?

One significant challenge is the high cost of hemoperfusion devices and procedures, which limits their accessibility, especially in low-income regions. Additionally, the complexity of treatment and need for skilled healthcare professionals can hinder widespread adoption. Regulatory hurdles and the lack of standardization in treatment protocols also pose obstacles.

What opportunities exist in the Hemoperfusion Production Market in 2025?

Opportunities lie in the rising global prevalence of kidney diseases, poisoning incidents, and toxin-related disorders, all of which fuel the demand for hemoperfusion treatments. Further market growth can come from ongoing R&D into improving device efficiency, reducing costs, and enhancing patient outcomes. Expansion into emerging markets presents another opportunity for increased market share.

What threats are present in the Hemoperfusion Production Market in 2025?

Intense competition from alternative therapies, such as dialysis and emerging treatments, poses a significant threat. The market also faces potential regulatory challenges, particularly with the evolving standards in medical device approval. Economic downturns and healthcare budget cuts in certain regions may further restrict growth opportunities.

What political factors influence the Hemoperfusion Production Market in 2025?

Government regulations around medical device approvals and healthcare policies significantly impact the Hemoperfusion Production Market. Political stability in key markets can encourage investment, while fluctuations in government healthcare spending or changes in reimbursement policies could affect the affordability and accessibility of hemoperfusion devices.

How do economic factors impact the Hemoperfusion Production Market in 2025?

The cost of hemoperfusion devices and treatments can be influenced by economic conditions, such as inflation, healthcare budgets, and purchasing power in different regions. Economic downturns may lead to reduced spending on non-essential healthcare, while growing economies may boost demand for advanced medical treatments and technologies.

What social factors affect the Hemoperfusion Production Market in 2025?

The increasing awareness of kidney-related disorders, toxin poisoning, and the need for advanced treatments is a major social factor. Aging populations in developed countries also contribute to a rise in chronic diseases, driving demand for hemoperfusion. Additionally, societal focus on improving patient care and outcomes supports the growth of this market.

What technological factors play a role in the Hemoperfusion Production Market in 2025?

Ongoing advancements in medical technologies, particularly in filtration and purification methods, improve the effectiveness of hemoperfusion treatments. Innovations in device design, such as making them more portable and user-friendly, also play a role in market growth. The development of more efficient and cost-effective technologies is essential for widespread adoption.

What environmental factors influence the Hemoperfusion Production Market in 2025?

Environmental factors include the increasing pressure on healthcare systems to be sustainable, with a focus on reducing waste and improving energy efficiency. As a result, the production of hemoperfusion devices may need to incorporate more sustainable practices, such as using recyclable materials or reducing the environmental footprint of manufacturing processes.

What legal factors affect the Hemoperfusion Production Market in 2025?

The hemoperfusion production market is subject to strict regulations regarding the safety, efficacy, and approval of medical devices. Legal challenges related to patents, intellectual property, and the protection of proprietary technologies could also arise. Compliance with international healthcare laws and regulations is essential for manufacturers to operate in multiple markets.

Who are the suppliers in the Hemoperfusion Production Market in 2025?

The suppliers in the Hemoperfusion Production Market include manufacturers of medical-grade materials, filtration devices, and other components required for hemoperfusion systems. Key suppliers are also companies providing technological innovations, such as AI or sensor technology, for device improvements. Additionally, suppliers include regulatory bodies providing certifications and approval for medical devices.

Who are the inputs for the Hemoperfusion Production Market in 2025?

Inputs include raw materials such as biocompatible polymers, filters, cartridges, and advanced materials used in the construction of hemoperfusion devices. Research and development (R&D) investment, intellectual property, and regulatory frameworks are critical inputs for innovation and device approval. Skilled labor and technological infrastructure are also essential inputs for production.

What processes are involved in the Hemoperfusion Production Market in 2025?

Key processes include R&D for device improvement, manufacturing of hemoperfusion systems, and testing for safety and efficacy. Regulatory approval processes are critical in ensuring the devices meet international standards. The marketing, distribution, and training of healthcare professionals on using these devices are also key processes in this market.

Who are the customers in the Hemoperfusion Production Market in 2025?

Customers include hospitals, clinics, and specialized treatment centers focusing on critical care, nephrology, and toxicology. Additionally, healthcare providers involved in managing acute kidney failure or poisoning cases form a major customer base. Public and private healthcare systems across both developed and emerging markets are key customers for hemoperfusion devices.

What are the outputs in the Hemoperfusion Production Market in 2025?

Outputs include fully developed, clinically approved hemoperfusion devices ready for use in medical settings. These devices typically offer solutions for acute poisoning, toxin removal, and renal failure treatment. Training materials, technical support services, and post-sale service packages are also key outputs supporting the market.

What is the threat of new entrants in the Hemoperfusion Production Market in 2025?

The threat of new entrants is moderate due to high barriers to entry, including significant capital investment, regulatory approvals, and specialized knowledge required for manufacturing hemoperfusion devices. However, with ongoing technological advancements and the growing demand for effective medical solutions, new entrants may still be encouraged to enter the market.

How intense is the bargaining power of suppliers in the Hemoperfusion Production Market in 2025?

The bargaining power of suppliers is moderate, as manufacturers rely on specialized raw materials and technologies for hemoperfusion devices. However, the increasing number of suppliers and the ongoing development of alternative materials and technologies help reduce supplier power, offering more options to device manufacturers.

What is the bargaining power of buyers in the Hemoperfusion Production Market in 2025?

The bargaining power of buyers is relatively high, especially for large hospitals and healthcare providers, as they can influence prices through bulk purchasing and long-term contracts. However, the specialized nature of hemoperfusion devices and the lack of widespread alternatives reduce the overall bargaining power for individual healthcare professionals or smaller institutions.

What is the threat of substitutes in the Hemoperfusion Production Market in 2025?

The threat of substitutes is moderate. While there are alternative treatments, such as dialysis for kidney failure or standard toxin removal therapies, hemoperfusion devices offer unique advantages in certain critical conditions like acute poisoning. However, the emergence of new treatment methods and technologies in the future could pose a potential substitute threat.

How competitive is the Hemoperfusion Production Market in 2025?

The market is highly competitive, with established players focusing on innovation and cost reduction to maintain market share. The presence of a few large manufacturers, alongside increasing competition from smaller, specialized companies, intensifies the competition. The race to develop more effective, user-friendly, and affordable hemoperfusion solutions is a key driver of competition in the market.

What raw materials are essential for the Hemoperfusion Production Market in 2025?

Key raw materials include biocompatible polymers, activated carbon, charcoal, and other materials used in filtration and adsorption processes. These materials are critical for constructing effective and safe hemoperfusion devices. Advanced materials for device casings and membranes also play a crucial role in ensuring high performance.

What are the key suppliers for Hemoperfusion production in 2025?

Key suppliers include manufacturers of specialized components such as filters, cartridges, and medical-grade polymers. Companies providing advanced technologies like sensors, data integration systems, and automation equipment are also crucial suppliers. Additionally, suppliers of research materials, scientific studies, and regulatory bodies ensure the device meets safety and efficacy standards.

How does research and development impact the upstream in the Hemoperfusion Production Market?

R&D is a driving force in the upstream segment of the Hemoperfusion Production Market. Ongoing research into new materials, more efficient filtration technologies, and improved treatment outcomes enhances the performance of hemoperfusion devices. R&D also helps manufacturers meet evolving regulatory standards and improve the cost-effectiveness of production processes.

What are the challenges in the upstream segment of the Hemoperfusion Production Market?

One significant challenge is sourcing high-quality, cost-effective materials required for the production of hemoperfusion devices. Additionally, the reliance on specialized suppliers for materials like biocompatible polymers or activated charcoal can lead to supply chain risks. The need for continuous innovation to meet regulatory standards and improve treatment outcomes can also be resource-intensive.

How do regulations affect the upstream segment of the Hemoperfusion Production Market?

Regulatory frameworks significantly affect the upstream processes, as manufacturers must comply with strict medical device standards and safety certifications. This can increase the time and cost involved in sourcing materials, testing, and production. Suppliers must also adhere to these regulations, which can impact their ability to provide timely and compliant materials for hemoperfusion production.

What are the key activities in the midstream segment of the Hemoperfusion Production Market in 2025?

In the midstream segment, key activities include the assembly and manufacturing of hemoperfusion devices, including the integration of filters, cartridges, and other components. Quality control, testing, and ensuring compliance with regulatory standards are crucial parts of this stage. Packaging and preparing devices for distribution also form a part of the midstream process.

How does technology impact the midstream in the Hemoperfusion Production Market?

Technology plays a significant role in the midstream by improving manufacturing processes through automation, precision engineering, and real-time quality monitoring. Advancements in manufacturing techniques, such as 3D printing and AI-driven design, also contribute to the efficiency and customization of hemoperfusion devices. These technologies help reduce production costs and improve device performance.

What are the key challenges in the midstream segment of the Hemoperfusion Production Market?

A key challenge is ensuring consistent product quality, as even small variations in the production process can affect the effectiveness of hemoperfusion devices. The need to meet stringent regulatory standards while maintaining cost-efficiency is another challenge. Additionally, supply chain disruptions or delays in sourcing specific components can lead to production bottlenecks.

How does the regulatory environment influence the midstream segment of the Hemoperfusion Production Market?

The regulatory environment has a significant influence on midstream activities, requiring manufacturers to comply with medical device safety and efficacy standards. This can affect the design, materials used, and the production process. Regulatory approvals and certifications are often time-consuming and costly but are essential to ensure the devices meet the required quality and safety standards for market entry.

What role do distribution channels play in the midstream segment of the Hemoperfusion Production Market?

Distribution channels play a critical role in ensuring that hemoperfusion devices reach healthcare providers efficiently. Partnerships with hospitals, clinics, and medical distributors are key for the successful delivery of products. The ability to manage inventory, logistics, and supply chains effectively helps in maintaining product availability and supporting the growth of the market.

What are the key activities in the downstream segment of the Hemoperfusion Production Market in 2025?

In the downstream segment, key activities include the distribution, sales, and use of hemoperfusion devices in healthcare settings. Healthcare providers such as hospitals, clinics, and specialized centers play a central role in utilizing these devices for patient care. Post-sales services, including maintenance, training, and technical support, are also essential activities in this stage.

How does customer demand affect the downstream in the Hemoperfusion Production Market?

Customer demand directly influences the downstream segment by driving the need for more advanced and effective hemoperfusion devices. Rising cases of kidney-related diseases, poisonings, and toxin-related conditions increase the demand for these devices. Additionally, healthcare institutions' focus on improving patient outcomes and expanding their treatment options further boosts market demand.

What challenges do healthcare providers face in the downstream segment of the Hemoperfusion Production Market?

Healthcare providers face challenges such as the high cost of hemoperfusion treatments, which can limit patient access, especially in low-resource settings. There is also the challenge of ensuring healthcare professionals are adequately trained to operate these devices effectively. Additionally, managing supply chain and inventory for these specialized devices can be complex, especially in emerging markets.

How do regulations impact the downstream segment of the Hemoperfusion Production Market?

Regulations in the downstream segment ensure that hemoperfusion devices are used correctly and safely in clinical settings. Healthcare institutions must comply with local health standards, which can influence device usage, pricing, and reimbursement. These regulations also impact the training and certification of healthcare providers who operate the devices.

What role does customer service play in the downstream segment of the Hemoperfusion Production Market?

Customer service plays a vital role in maintaining strong relationships with healthcare providers. This includes offering post-sale support such as device maintenance, troubleshooting, and technical assistance. Effective customer service can improve user experience, enhance the longevity of devices, and ensure that healthcare providers continue to rely on these systems for patient care.

Chapter 1, to describe Hemoperfusion Production product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hemoperfusion Production, with price, sales, revenue and global market share of Hemoperfusion Production from 2018 to 2023.
Chapter 3, the Hemoperfusion Production competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hemoperfusion Production breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hemoperfusion Production market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hemoperfusion Production.
Chapter 14 and 15, to describe Hemoperfusion Production sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Hemoperfusion Production
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Hemoperfusion Production Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Resin Adsorption
       1.3.3 Activated Carbon Adsorption
       1.3.4 Others
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Hemoperfusion Production Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Overdose
       1.4.3 Specific Intoxications
       1.4.4 Certain Autoimmune Diseases
       1.4.5 Hepatic Encephalopathy
       1.4.6 Others
   1.5 Global Hemoperfusion Production Market Size & Forecast
       1.5.1 Global Hemoperfusion Production Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Hemoperfusion Production Sales Quantity (2018-2029)
       1.5.3 Global Hemoperfusion Production Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 Jafron Biomedical
       2.1.1 Jafron Biomedical Details
       2.1.2 Jafron Biomedical Major Business
       2.1.3 Jafron Biomedical Hemoperfusion Production Product and Services
       2.1.4 Jafron Biomedical Hemoperfusion Production Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Jafron Biomedical Recent Developments/Updates
   2.2 Baxter (Gambro)
       2.2.1 Baxter (Gambro) Details
       2.2.2 Baxter (Gambro) Major Business
       2.2.3 Baxter (Gambro) Hemoperfusion Production Product and Services
       2.2.4 Baxter (Gambro) Hemoperfusion Production Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Baxter (Gambro) Recent Developments/Updates
   2.3 Biosun Medical
       2.3.1 Biosun Medical Details
       2.3.2 Biosun Medical Major Business
       2.3.3 Biosun Medical Hemoperfusion Production Product and Services
       2.3.4 Biosun Medical Hemoperfusion Production Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Biosun Medical Recent Developments/Updates
   2.4 Toray Medical
       2.4.1 Toray Medical Details
       2.4.2 Toray Medical Major Business
       2.4.3 Toray Medical Hemoperfusion Production Product and Services
       2.4.4 Toray Medical Hemoperfusion Production Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Toray Medical Recent Developments/Updates
   2.5 Asahi-Kasei
       2.5.1 Asahi-Kasei Details
       2.5.2 Asahi-Kasei Major Business
       2.5.3 Asahi-Kasei Hemoperfusion Production Product and Services
       2.5.4 Asahi-Kasei Hemoperfusion Production Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Asahi-Kasei Recent Developments/Updates
   2.6 Kaneka
       2.6.1 Kaneka Details
       2.6.2 Kaneka Major Business
       2.6.3 Kaneka Hemoperfusion Production Product and Services
       2.6.4 Kaneka Hemoperfusion Production Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Kaneka Recent Developments/Updates
   2.7 Zibo Kangbei
       2.7.1 Zibo Kangbei Details
       2.7.2 Zibo Kangbei Major Business
       2.7.3 Zibo Kangbei Hemoperfusion Production Product and Services
       2.7.4 Zibo Kangbei Hemoperfusion Production Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Zibo Kangbei Recent Developments/Updates
   2.8 Aier
       2.8.1 Aier Details
       2.8.2 Aier Major Business
       2.8.3 Aier Hemoperfusion Production Product and Services
       2.8.4 Aier Hemoperfusion Production Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Aier Recent Developments/Updates
   2.9 Cytosorbents
       2.9.1 Cytosorbents Details
       2.9.2 Cytosorbents Major Business
       2.9.3 Cytosorbents Hemoperfusion Production Product and Services
       2.9.4 Cytosorbents Hemoperfusion Production Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Cytosorbents Recent Developments/Updates

3 Competitive Environment: Hemoperfusion Production by Manufacturer

   3.1 Global Hemoperfusion Production Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Hemoperfusion Production Revenue by Manufacturer (2018-2023)
   3.3 Global Hemoperfusion Production Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Hemoperfusion Production by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Hemoperfusion Production Manufacturer Market Share in 2022
       3.4.2 Top 6 Hemoperfusion Production Manufacturer Market Share in 2022
   3.5 Hemoperfusion Production Market: Overall Company Footprint Analysis
       3.5.1 Hemoperfusion Production Market: Region Footprint
       3.5.2 Hemoperfusion Production Market: Company Product Type Footprint
       3.5.3 Hemoperfusion Production Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Hemoperfusion Production Market Size by Region
       4.1.1 Global Hemoperfusion Production Sales Quantity by Region (2018-2029)
       4.1.2 Global Hemoperfusion Production Consumption Value by Region (2018-2029)
       4.1.3 Global Hemoperfusion Production Average Price by Region (2018-2029)
   4.2 North America Hemoperfusion Production Consumption Value (2018-2029)
   4.3 Europe Hemoperfusion Production Consumption Value (2018-2029)
   4.4 Asia-Pacific Hemoperfusion Production Consumption Value (2018-2029)
   4.5 South America Hemoperfusion Production Consumption Value (2018-2029)
   4.6 Middle East and Africa Hemoperfusion Production Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Hemoperfusion Production Sales Quantity by Type (2018-2029)
   5.2 Global Hemoperfusion Production Consumption Value by Type (2018-2029)
   5.3 Global Hemoperfusion Production Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Hemoperfusion Production Sales Quantity by Application (2018-2029)
   6.2 Global Hemoperfusion Production Consumption Value by Application (2018-2029)
   6.3 Global Hemoperfusion Production Average Price by Application (2018-2029)

7 North America

   7.1 North America Hemoperfusion Production Sales Quantity by Type (2018-2029)
   7.2 North America Hemoperfusion Production Sales Quantity by Application (2018-2029)
   7.3 North America Hemoperfusion Production Market Size by Country
       7.3.1 North America Hemoperfusion Production Sales Quantity by Country (2018-2029)
       7.3.2 North America Hemoperfusion Production Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Hemoperfusion Production Sales Quantity by Type (2018-2029)
   8.2 Europe Hemoperfusion Production Sales Quantity by Application (2018-2029)
   8.3 Europe Hemoperfusion Production Market Size by Country
       8.3.1 Europe Hemoperfusion Production Sales Quantity by Country (2018-2029)
       8.3.2 Europe Hemoperfusion Production Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Hemoperfusion Production Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Hemoperfusion Production Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Hemoperfusion Production Market Size by Region
       9.3.1 Asia-Pacific Hemoperfusion Production Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Hemoperfusion Production Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Hemoperfusion Production Sales Quantity by Type (2018-2029)
   10.2 South America Hemoperfusion Production Sales Quantity by Application (2018-2029)
   10.3 South America Hemoperfusion Production Market Size by Country
       10.3.1 South America Hemoperfusion Production Sales Quantity by Country (2018-2029)
       10.3.2 South America Hemoperfusion Production Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Hemoperfusion Production Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Hemoperfusion Production Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Hemoperfusion Production Market Size by Country
       11.3.1 Middle East & Africa Hemoperfusion Production Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Hemoperfusion Production Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Hemoperfusion Production Market Drivers
   12.2 Hemoperfusion Production Market Restraints
   12.3 Hemoperfusion Production Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Hemoperfusion Production and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Hemoperfusion Production
   13.3 Hemoperfusion Production Production Process
   13.4 Hemoperfusion Production Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Hemoperfusion Production Typical Distributors
   14.3 Hemoperfusion Production Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Hemoperfusion Production Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Hemoperfusion Production Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Jafron Biomedical Basic Information, Manufacturing Base and Competitors
   Table 4. Jafron Biomedical Major Business
   Table 5. Jafron Biomedical Hemoperfusion Production Product and Services
   Table 6. Jafron Biomedical Hemoperfusion Production Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. Jafron Biomedical Recent Developments/Updates
   Table 8. Baxter (Gambro) Basic Information, Manufacturing Base and Competitors
   Table 9. Baxter (Gambro) Major Business
   Table 10. Baxter (Gambro) Hemoperfusion Production Product and Services
   Table 11. Baxter (Gambro) Hemoperfusion Production Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. Baxter (Gambro) Recent Developments/Updates
   Table 13. Biosun Medical Basic Information, Manufacturing Base and Competitors
   Table 14. Biosun Medical Major Business
   Table 15. Biosun Medical Hemoperfusion Production Product and Services
   Table 16. Biosun Medical Hemoperfusion Production Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Biosun Medical Recent Developments/Updates
   Table 18. Toray Medical Basic Information, Manufacturing Base and Competitors
   Table 19. Toray Medical Major Business
   Table 20. Toray Medical Hemoperfusion Production Product and Services
   Table 21. Toray Medical Hemoperfusion Production Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. Toray Medical Recent Developments/Updates
   Table 23. Asahi-Kasei Basic Information, Manufacturing Base and Competitors
   Table 24. Asahi-Kasei Major Business
   Table 25. Asahi-Kasei Hemoperfusion Production Product and Services
   Table 26. Asahi-Kasei Hemoperfusion Production Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. Asahi-Kasei Recent Developments/Updates
   Table 28. Kaneka Basic Information, Manufacturing Base and Competitors
   Table 29. Kaneka Major Business
   Table 30. Kaneka Hemoperfusion Production Product and Services
   Table 31. Kaneka Hemoperfusion Production Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. Kaneka Recent Developments/Updates
   Table 33. Zibo Kangbei Basic Information, Manufacturing Base and Competitors
   Table 34. Zibo Kangbei Major Business
   Table 35. Zibo Kangbei Hemoperfusion Production Product and Services
   Table 36. Zibo Kangbei Hemoperfusion Production Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 37. Zibo Kangbei Recent Developments/Updates
   Table 38. Aier Basic Information, Manufacturing Base and Competitors
   Table 39. Aier Major Business
   Table 40. Aier Hemoperfusion Production Product and Services
   Table 41. Aier Hemoperfusion Production Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 42. Aier Recent Developments/Updates
   Table 43. Cytosorbents Basic Information, Manufacturing Base and Competitors
   Table 44. Cytosorbents Major Business
   Table 45. Cytosorbents Hemoperfusion Production Product and Services
   Table 46. Cytosorbents Hemoperfusion Production Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 47. Cytosorbents Recent Developments/Updates
   Table 48. Global Hemoperfusion Production Sales Quantity by Manufacturer (2018-2023) & (K Units)
   Table 49. Global Hemoperfusion Production Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 50. Global Hemoperfusion Production Average Price by Manufacturer (2018-2023) & (USD/Unit)
   Table 51. Market Position of Manufacturers in Hemoperfusion Production, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 52. Head Office and Hemoperfusion Production Production Site of Key Manufacturer
   Table 53. Hemoperfusion Production Market: Company Product Type Footprint
   Table 54. Hemoperfusion Production Market: Company Product Application Footprint
   Table 55. Hemoperfusion Production New Market Entrants and Barriers to Market Entry
   Table 56. Hemoperfusion Production Mergers, Acquisition, Agreements, and Collaborations
   Table 57. Global Hemoperfusion Production Sales Quantity by Region (2018-2023) & (K Units)
   Table 58. Global Hemoperfusion Production Sales Quantity by Region (2024-2029) & (K Units)
   Table 59. Global Hemoperfusion Production Consumption Value by Region (2018-2023) & (USD Million)
   Table 60. Global Hemoperfusion Production Consumption Value by Region (2024-2029) & (USD Million)
   Table 61. Global Hemoperfusion Production Average Price by Region (2018-2023) & (USD/Unit)
   Table 62. Global Hemoperfusion Production Average Price by Region (2024-2029) & (USD/Unit)
   Table 63. Global Hemoperfusion Production Sales Quantity by Type (2018-2023) & (K Units)
   Table 64. Global Hemoperfusion Production Sales Quantity by Type (2024-2029) & (K Units)
   Table 65. Global Hemoperfusion Production Consumption Value by Type (2018-2023) & (USD Million)
   Table 66. Global Hemoperfusion Production Consumption Value by Type (2024-2029) & (USD Million)
   Table 67. Global Hemoperfusion Production Average Price by Type (2018-2023) & (USD/Unit)
   Table 68. Global Hemoperfusion Production Average Price by Type (2024-2029) & (USD/Unit)
   Table 69. Global Hemoperfusion Production Sales Quantity by Application (2018-2023) & (K Units)
   Table 70. Global Hemoperfusion Production Sales Quantity by Application (2024-2029) & (K Units)
   Table 71. Global Hemoperfusion Production Consumption Value by Application (2018-2023) & (USD Million)
   Table 72. Global Hemoperfusion Production Consumption Value by Application (2024-2029) & (USD Million)
   Table 73. Global Hemoperfusion Production Average Price by Application (2018-2023) & (USD/Unit)
   Table 74. Global Hemoperfusion Production Average Price by Application (2024-2029) & (USD/Unit)
   Table 75. North America Hemoperfusion Production Sales Quantity by Type (2018-2023) & (K Units)
   Table 76. North America Hemoperfusion Production Sales Quantity by Type (2024-2029) & (K Units)
   Table 77. North America Hemoperfusion Production Sales Quantity by Application (2018-2023) & (K Units)
   Table 78. North America Hemoperfusion Production Sales Quantity by Application (2024-2029) & (K Units)
   Table 79. North America Hemoperfusion Production Sales Quantity by Country (2018-2023) & (K Units)
   Table 80. North America Hemoperfusion Production Sales Quantity by Country (2024-2029) & (K Units)
   Table 81. North America Hemoperfusion Production Consumption Value by Country (2018-2023) & (USD Million)
   Table 82. North America Hemoperfusion Production Consumption Value by Country (2024-2029) & (USD Million)
   Table 83. Europe Hemoperfusion Production Sales Quantity by Type (2018-2023) & (K Units)
   Table 84. Europe Hemoperfusion Production Sales Quantity by Type (2024-2029) & (K Units)
   Table 85. Europe Hemoperfusion Production Sales Quantity by Application (2018-2023) & (K Units)
   Table 86. Europe Hemoperfusion Production Sales Quantity by Application (2024-2029) & (K Units)
   Table 87. Europe Hemoperfusion Production Sales Quantity by Country (2018-2023) & (K Units)
   Table 88. Europe Hemoperfusion Production Sales Quantity by Country (2024-2029) & (K Units)
   Table 89. Europe Hemoperfusion Production Consumption Value by Country (2018-2023) & (USD Million)
   Table 90. Europe Hemoperfusion Production Consumption Value by Country (2024-2029) & (USD Million)
   Table 91. Asia-Pacific Hemoperfusion Production Sales Quantity by Type (2018-2023) & (K Units)
   Table 92. Asia-Pacific Hemoperfusion Production Sales Quantity by Type (2024-2029) & (K Units)
   Table 93. Asia-Pacific Hemoperfusion Production Sales Quantity by Application (2018-2023) & (K Units)
   Table 94. Asia-Pacific Hemoperfusion Production Sales Quantity by Application (2024-2029) & (K Units)
   Table 95. Asia-Pacific Hemoperfusion Production Sales Quantity by Region (2018-2023) & (K Units)
   Table 96. Asia-Pacific Hemoperfusion Production Sales Quantity by Region (2024-2029) & (K Units)
   Table 97. Asia-Pacific Hemoperfusion Production Consumption Value by Region (2018-2023) & (USD Million)
   Table 98. Asia-Pacific Hemoperfusion Production Consumption Value by Region (2024-2029) & (USD Million)
   Table 99. South America Hemoperfusion Production Sales Quantity by Type (2018-2023) & (K Units)
   Table 100. South America Hemoperfusion Production Sales Quantity by Type (2024-2029) & (K Units)
   Table 101. South America Hemoperfusion Production Sales Quantity by Application (2018-2023) & (K Units)
   Table 102. South America Hemoperfusion Production Sales Quantity by Application (2024-2029) & (K Units)
   Table 103. South America Hemoperfusion Production Sales Quantity by Country (2018-2023) & (K Units)
   Table 104. South America Hemoperfusion Production Sales Quantity by Country (2024-2029) & (K Units)
   Table 105. South America Hemoperfusion Production Consumption Value by Country (2018-2023) & (USD Million)
   Table 106. South America Hemoperfusion Production Consumption Value by Country (2024-2029) & (USD Million)
   Table 107. Middle East & Africa Hemoperfusion Production Sales Quantity by Type (2018-2023) & (K Units)
   Table 108. Middle East & Africa Hemoperfusion Production Sales Quantity by Type (2024-2029) & (K Units)
   Table 109. Middle East & Africa Hemoperfusion Production Sales Quantity by Application (2018-2023) & (K Units)
   Table 110. Middle East & Africa Hemoperfusion Production Sales Quantity by Application (2024-2029) & (K Units)
   Table 111. Middle East & Africa Hemoperfusion Production Sales Quantity by Region (2018-2023) & (K Units)
   Table 112. Middle East & Africa Hemoperfusion Production Sales Quantity by Region (2024-2029) & (K Units)
   Table 113. Middle East & Africa Hemoperfusion Production Consumption Value by Region (2018-2023) & (USD Million)
   Table 114. Middle East & Africa Hemoperfusion Production Consumption Value by Region (2024-2029) & (USD Million)
   Table 115. Hemoperfusion Production Raw Material
   Table 116. Key Manufacturers of Hemoperfusion Production Raw Materials
   Table 117. Hemoperfusion Production Typical Distributors
   Table 118. Hemoperfusion Production Typical Customers

List of Figures

   Figure 1. Hemoperfusion Production Picture
   Figure 2. Global Hemoperfusion Production Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Hemoperfusion Production Consumption Value Market Share by Type in 2022
   Figure 4. Resin Adsorption Examples
   Figure 5. Activated Carbon Adsorption Examples
   Figure 6. Others Examples
   Figure 7. Global Hemoperfusion Production Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 8. Global Hemoperfusion Production Consumption Value Market Share by Application in 2022
   Figure 9. Overdose Examples
   Figure 10. Specific Intoxications Examples
   Figure 11. Certain Autoimmune Diseases Examples
   Figure 12. Hepatic Encephalopathy Examples
   Figure 13. Others Examples
   Figure 14. Global Hemoperfusion Production Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 15. Global Hemoperfusion Production Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 16. Global Hemoperfusion Production Sales Quantity (2018-2029) & (K Units)
   Figure 17. Global Hemoperfusion Production Average Price (2018-2029) & (USD/Unit)
   Figure 18. Global Hemoperfusion Production Sales Quantity Market Share by Manufacturer in 2022
   Figure 19. Global Hemoperfusion Production Consumption Value Market Share by Manufacturer in 2022
   Figure 20. Producer Shipments of Hemoperfusion Production by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 21. Top 3 Hemoperfusion Production Manufacturer (Consumption Value) Market Share in 2022
   Figure 22. Top 6 Hemoperfusion Production Manufacturer (Consumption Value) Market Share in 2022
   Figure 23. Global Hemoperfusion Production Sales Quantity Market Share by Region (2018-2029)
   Figure 24. Global Hemoperfusion Production Consumption Value Market Share by Region (2018-2029)
   Figure 25. North America Hemoperfusion Production Consumption Value (2018-2029) & (USD Million)
   Figure 26. Europe Hemoperfusion Production Consumption Value (2018-2029) & (USD Million)
   Figure 27. Asia-Pacific Hemoperfusion Production Consumption Value (2018-2029) & (USD Million)
   Figure 28. South America Hemoperfusion Production Consumption Value (2018-2029) & (USD Million)
   Figure 29. Middle East & Africa Hemoperfusion Production Consumption Value (2018-2029) & (USD Million)
   Figure 30. Global Hemoperfusion Production Sales Quantity Market Share by Type (2018-2029)
   Figure 31. Global Hemoperfusion Production Consumption Value Market Share by Type (2018-2029)
   Figure 32. Global Hemoperfusion Production Average Price by Type (2018-2029) & (USD/Unit)
   Figure 33. Global Hemoperfusion Production Sales Quantity Market Share by Application (2018-2029)
   Figure 34. Global Hemoperfusion Production Consumption Value Market Share by Application (2018-2029)
   Figure 35. Global Hemoperfusion Production Average Price by Application (2018-2029) & (USD/Unit)
   Figure 36. North America Hemoperfusion Production Sales Quantity Market Share by Type (2018-2029)
   Figure 37. North America Hemoperfusion Production Sales Quantity Market Share by Application (2018-2029)
   Figure 38. North America Hemoperfusion Production Sales Quantity Market Share by Country (2018-2029)
   Figure 39. North America Hemoperfusion Production Consumption Value Market Share by Country (2018-2029)
   Figure 40. United States Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 41. Canada Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 42. Mexico Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 43. Europe Hemoperfusion Production Sales Quantity Market Share by Type (2018-2029)
   Figure 44. Europe Hemoperfusion Production Sales Quantity Market Share by Application (2018-2029)
   Figure 45. Europe Hemoperfusion Production Sales Quantity Market Share by Country (2018-2029)
   Figure 46. Europe Hemoperfusion Production Consumption Value Market Share by Country (2018-2029)
   Figure 47. Germany Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. France Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 49. United Kingdom Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 50. Russia Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 51. Italy Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 52. Asia-Pacific Hemoperfusion Production Sales Quantity Market Share by Type (2018-2029)
   Figure 53. Asia-Pacific Hemoperfusion Production Sales Quantity Market Share by Application (2018-2029)
   Figure 54. Asia-Pacific Hemoperfusion Production Sales Quantity Market Share by Region (2018-2029)
   Figure 55. Asia-Pacific Hemoperfusion Production Consumption Value Market Share by Region (2018-2029)
   Figure 56. China Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. Japan Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. Korea Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 59. India Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 60. Southeast Asia Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 61. Australia Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 62. South America Hemoperfusion Production Sales Quantity Market Share by Type (2018-2029)
   Figure 63. South America Hemoperfusion Production Sales Quantity Market Share by Application (2018-2029)
   Figure 64. South America Hemoperfusion Production Sales Quantity Market Share by Country (2018-2029)
   Figure 65. South America Hemoperfusion Production Consumption Value Market Share by Country (2018-2029)
   Figure 66. Brazil Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 67. Argentina Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 68. Middle East & Africa Hemoperfusion Production Sales Quantity Market Share by Type (2018-2029)
   Figure 69. Middle East & Africa Hemoperfusion Production Sales Quantity Market Share by Application (2018-2029)
   Figure 70. Middle East & Africa Hemoperfusion Production Sales Quantity Market Share by Region (2018-2029)
   Figure 71. Middle East & Africa Hemoperfusion Production Consumption Value Market Share by Region (2018-2029)
   Figure 72. Turkey Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 73. Egypt Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 74. Saudi Arabia Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 75. South Africa Hemoperfusion Production Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 76. Hemoperfusion Production Market Drivers
   Figure 77. Hemoperfusion Production Market Restraints
   Figure 78. Hemoperfusion Production Market Trends
   Figure 79. Porters Five Forces Analysis
   Figure 80. Manufacturing Cost Structure Analysis of Hemoperfusion Production in 2022
   Figure 81. Manufacturing Process Analysis of Hemoperfusion Production
   Figure 82. Hemoperfusion Production Industrial Chain
   Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 84. Direct Channel Pros & Cons
   Figure 85. Indirect Channel Pros & Cons
   Figure 86. Methodology
   Figure 87. Research Process and Data Source